Rigel Pharmaceuticals
RIGL
#6732
Rank
A$1.14 B
Marketcap
A$60.82
Share price
6.05%
Change (1 day)
14.46%
Change (1 year)

Rigel Pharmaceuticals (RIGL) Fails to deliver data

Key failure to deliver metrics for Rigel Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Rigel Pharmaceuticals (RIGL) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Rigel Pharmaceuticals (RIGL) - since 2013

Volume in USD (price x number of shares), data since 2013

Rigel Pharmaceuticals (RIGL) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$0.03 M-97.08%
2023A$1.11 M-68.64%
2022A$3.56 M-47.14%
2021A$6.75 M159.94%
2020A$2.59 M284.04%
2019A$0.67 M-85.02%
2018A$4.51 M17.28%
2017A$3.85 M24.72%
2016A$3.08 M166.47%
2015A$1.15 M-47.8%
2014A$2.21 M151.65%
2013A$0.88 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Amgen
AMGN
A$25.92 MA$0.45 B๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
N/AA$0.14 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
A$1.32 MA$5.69 M๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
A$0.23 MA$0.23 M๐Ÿ‡บ๐Ÿ‡ธ USA